General Information of Drug Therapeutic Target (DTT) (ID: TTCFSPE)

DTT Name Carbonic anhydrase VI (CA-VI)
Synonyms Secreted carbonic anhydrase; Salivary carbonic anhydrase; Carbonic anhydrase 6; Carbonate dehydratase VI
Gene Name CA6
DTT Type
Successful target
[1]
Related Disease
Bacterial infection [ICD-11: 1A00-1C4Z]
Seborrhoeic dermatitis [ICD-11: EA81]
BioChemical Class
Alpha-carbonic anhydrase
UniProt ID
CAH6_HUMAN
TTD ID
T06569
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
EC 4.2.1.1
Sequence
MRALVLLLSLFLLGGQAQHVSDWTYSEGALDEAHWPQHYPACGGQRQSPINLQRTKVRYN
PSLKGLNMTGYETQAGEFPMVNNGHTVQISLPSTMRMTVADGTVYIAQQMHFHWGGASSE
ISGSEHTVDGIRHVIEIHIVHYNSKYKSYDIAQDAPDGLAVLAAFVEVKNYPENTYYSNF
ISHLANIKYPGQRTTLTGLDVQDMLPRNLQHYYTYHGSLTTPPCTENVHWFVLADFVKLS
RTQVWKLENSLLDHRNKTIHNDYRRTQPLNHRVVESNFPNQEYTLGSEFQFYLHKIEEIL
DYLRRALN
Function Its role in saliva is unknown. Reversible hydration of carbon dioxide.
KEGG Pathway
( )
Reactome Pathway
Reversible hydration of carbon dioxide (R-HSA-1475029 )

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
2 Approved Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Salicyclic acid DM2F8XZ Seborrhoeic dermatitis EA81 Approved [2]
Sulfamylon DMIO1K0 Bacterial infection 1A00-1C4Z Approved [1]
------------------------------------------------------------------------------------
4 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [3]
PARABEN DMEW5Z8 N. A. N. A. Phase 3 [4]
Coumate DMVKW0N Breast cancer 2C60-2C65 Phase 2 [5]
SAR566658 DM6Q295 Solid tumour/cancer 2A00-2F9Z Phase 2 [6]
------------------------------------------------------------------------------------
1 Patented Agent(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ferulic Acid DMJC7NF Discovery agent N.A. Patented [4]
------------------------------------------------------------------------------------
1 Discontinued Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Spermine DMD4BFY N. A. N. A. Terminated [7]
------------------------------------------------------------------------------------
39 Investigative Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
2,4-Disulfamyltrifluoromethylaniline DM2AW0Z Discovery agent N.A. Investigative [1]
2-Amino-benzenesulfonamide DMEMANH Discovery agent N.A. Investigative [1]
2-hydrazinylbenzenesulfonamide DMCNXZM Discovery agent N.A. Investigative [1]
4-(2-aminopyrimidin-4-ylamino)benzenesulfonamide DMWG706 Discovery agent N.A. Investigative [1]
4-(2-Hydroxy-ethyl)-benzenesulfonamide DM1C5U6 Discovery agent N.A. Investigative [1]
4-(hydroxymethyl)benzenesulfonamide DMR6VWL Discovery agent N.A. Investigative [1]
4-Amino-3-bromo-benzenesulfonamide DMVUCZK Discovery agent N.A. Investigative [1]
4-Amino-3-chloro-benzenesulfonamide DMERTQ4 Discovery agent N.A. Investigative [1]
4-Amino-3-fluoro-benzenesulfonamide DMIQ3VR Discovery agent N.A. Investigative [1]
4-Amino-3-iodo-benzenesulfonamide DMCOYHR Discovery agent N.A. Investigative [1]
4-amino-6-chlorobenzene-1,3-disulfonamide DMIWGZS Discovery agent N.A. Investigative [1]
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide DMJZNX6 Discovery agent N.A. Investigative [1]
4-CYANOPHENOL DMN12EX Discovery agent N.A. Investigative [2]
4-Hydrazino-benzenesulfonamide DM49B18 Discovery agent N.A. Investigative [1]
6-(aminomethyl)-2H-chromen-2-one DMJU9TG Discovery agent N.A. Investigative [8]
6-(hydroxymethyl)-2H-chromen-2-one DM5TOX2 Discovery agent N.A. Investigative [8]
6-Hydroxy-benzothiazole-2-sulfonic acid amide DM2B4S5 Discovery agent N.A. Investigative [1]
7-butoxy-2H-chromen-2-one DM78C5A Discovery agent N.A. Investigative [8]
7-propoxy-2H-chromen-2-one DMD5CB6 Discovery agent N.A. Investigative [8]
BENZOLAMIDE DME5QPX Discovery agent N.A. Investigative [1]
Carzenide DMVD481 Discovery agent N.A. Investigative [1]
CATECHIN DMY38SB Discovery agent N.A. Investigative [3]
CL-5343 DM9AFZ3 Solid tumour/cancer 2A00-2F9Z Investigative [9]
Coumarin DM0N8ZM Discovery agent N.A. Investigative [8]
Decane-1,10-diyl disulfamate DM1ESVR Discovery agent N.A. Investigative [10]
Decyl sulfamate DMIERWO Discovery agent N.A. Investigative [10]
ELLAGIC ACID DMX8BS5 Discovery agent N.A. Investigative [4]
Ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate DMWIB0V Discovery agent N.A. Investigative [8]
GALLICACID DM6Y3A0 Discovery agent N.A. Investigative [4]
HERNIARIN DM9UASM Discovery agent N.A. Investigative [8]
Hexane-1,6-diamine DMSHF0K Discovery agent N.A. Investigative [7]
N1-(2-aminoethyl)ethane-1,2-diamine DM6HM5S Discovery agent N.A. Investigative [7]
N1-(naphthalen-1-yl)ethane-1,2-diamine DMYGCSV Discovery agent N.A. Investigative [7]
Octane-1,8-diyl disulfamate DMBQMGH Discovery agent N.A. Investigative [10]
Octyl sulfamate DM40ZCA Discovery agent N.A. Investigative [10]
P-Coumaric Acid DMGJSVD Discovery agent N.A. Investigative [4]
P-toluenesulfonamide DMPEKTO Discovery agent N.A. Investigative [1]
Pentane-1,5-diamine DMVPZG9 Discovery agent N.A. Investigative [7]
Syringic Acid DM802V7 Discovery agent N.A. Investigative [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 39 Investigative Drug(s)

Molecular Expression Atlas (MEA) of This DTT

Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This DTT
Disease Name ICD 11 Studied Tissue p-value Fold-Change Z-score
Breast cancer 2C82 Breast tissue 3.64E-10 -0.17 -0.37
------------------------------------------------------------------------------------

References

1 Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV. J Med Chem. 2009 Feb 12;52(3):646-54.
2 Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid. Bioorg Med Chem. 2008 Aug 1;16(15):7424-8.
3 Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5050-3.
4 Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-2164.
5 Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-r... Bioorg Med Chem Lett. 2008 Aug 1;18(15):4282-6.
6 An Antibody-Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities. Mol Cancer Ther. 2020 Aug;19(8):1660-1669.
7 Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. J Med Chem. 2010 Aug 12;53(15):5511-22.
8 Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem. 2010 Jan 14;53(1):335-44.
9 Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a l... Bioorg Med Chem Lett. 2010 Aug 1;20(15):4376-81.
10 Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis-sulfamate adducts with isozymes II and IX as a platform for designing tight-bi... J Med Chem. 2009 Oct 8;52(19):5990-8.